Since S1PR2 signaling counteracts the pro-migratory functions of S1PR1 in leukocytes, one might argue that antagonizing S1PR2 could serve as potential target in cancer therapy by strengthening the chances to turn immunologically cold tumors into hot tumors. Here, S1PR2 is linked to cancer.